##semicolon##
миелодиспластический синдром, перегрузка железом, ферритин, сывороточное железо, переливание крови, ферротерапия.##submission.citations##
Cakar MK, Yegin ZA, Baysal NA, et al. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome. Transfus Apher Sci. 2013; 48: 397 – 401.
Goldberg S.L. et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. // J. Clin. Oncol. 2010. Vol. 28, № 17. P. 2847–2852.
Greenberg P.L. et al. Revised international prognostic scoring system for myelodysplastic syndromes // Blood. 2012. Vol. 120, № 12. P. 2454–2465
Kikuchi S, Kobune M, Iyama S, et al. Prognostic significance of serum ferritin concentration at diagnosis in myelodysplastic syndrome. Int J Hematol. 2012; 95: 527– 534.
"Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version". NCI. 12 August 2015. Archived from the original on 5 October 2016. Retrieved 27 October 2016.
Mufti G.J. et al. Diagnosis and classification of myelodysplastic syndrome: International 67 Working Group on Morphology of myelodysplastic syndrome (IWGM–MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. // Haematologica. 2008. Vol. 93, № 11. P. 1712–1717
Pilo, F., Di Tucci, A. A., Dessalvi, P., Caddori, A., & Angelucci, E. (2010). The evolving clinical scenario of myelodysplastic syndrome: The need for a complete and up to date upfront diagnostic assessment. European Journal of Internal Medicine, 21(6), 490–495. doi:10.1016/j.ejim.2010.09.003
Seguier J. et al. Autoimmune diseases in myelodysplastic syndrome favors patient’s survival: A case control study and literature review. // Autoimmun. Rev. 2019. Vol. 18, № 1. P. 36–42
Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y Impact of iron overload and potential benefit from iron chelation in low–risk myelodysplastic syndrome. Blood. 2014; 124: 873 – 881.
Swerdlow S.H. et al. WHO classification of tumors of hematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: International Agency for Research in Cancer (IARC) / ed. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H T.J. 2017. 585p.
Wong, C. A. C., Wong, S. A. Y., & Leitch, H. A. (2018). Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy. Leukemia Research, 67, 75–81. doi:10.1016/j.leukres.2018.02.